相关实验视频

Updated: Jan 29, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Published on: June 29, 2011

细胞染色体c氧化酶子单元COX4-1重编程埃拉斯诱导的细胞死亡从铁亡到细胞亡:一种转移性线粒体研究

Claudia R Oliva¹, Susanne Flor¹, Corinne E Griguer¹

¹Free Radical & Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, IA 52242, USA.

Antioxidants (Basel, Switzerland)

|January 28, 2026

概括

线粒体COX4-1保护质母细胞细胞免受铁亡,一种细胞死亡形式. 这种COX4-1异型重新连接细胞代谢,促进细胞亡,而不是铁亡,可能导致治疗耐药性.

科学领域:

细胞生物学细胞生物学
生物化学生物化学
在瘤学瘤学.

背景情况:

铁亡是依赖铁的细胞死亡途径,在质母细胞瘤治疗中至关重要.
影响铁亡的线粒体因素在很大程度上是未知的.
细胞染色体c氧化酶亚单元IV (COX4) 有两个异型:COX4-1和COX4-2.

研究的目的:

为了研究线粒体COX4异构体在质母细胞瘤中ferroptosis敏感性中的作用.
为了区分线粒体与核对铁灭调节的贡献.

主要方法:

使用了CRISPR生成的POLG-knockout的p^{0细胞和转化 mitochondrial 混合体.}
与含有线粒体的COX4-1或COX4-2复合的混合体.
分析了细胞死亡途径,性铁水平,囊的吸收和铁灭标记物的表达 (SLC7A11,GPX4).

主要成果:

携带COX4-1的线粒体对埃拉斯诱导的铁灭产生了抵抗力.
在COX4-1杂交物种中,表现出可变铁的减少,囊的摄取减少,以及SLC7A11/GPX4表达的降低.
有COX4-1线粒体的细胞在治疗埃拉斯后经历了亡,而不是铁亡.
COX4-2 杂交体仍然对埃拉斯诱导的铁死敏感.

结论:

线粒体COX4-1异型决定了细胞死亡的命运,将信号从铁亡转移到亡.
异形特异性线粒体组成是调节细胞死亡的新决定因素.
COX4-1介导的线粒体重塑可能是质母细胞瘤治疗耐药性的机制.

关键词:

这种COX4-1异型是COX4-1异型.灭症 (apoptosis) 是一种死亡的过程.埃拉斯廷没有离开.铁性化 (ferroptosis) 是一种质瘤质瘤是一种跨 mitochondrial 杂交物种跨 mitochondrial 杂交物种

更多相关视频

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis

Published on: February 16, 2015

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

相关概念视频

Autophagic Cell Death

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

Overview of Cell Death

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

Apoptosis

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...